Global Transcatheter Heart Valve Replacement Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong>, Patient Numbers, by Position (TMVR,<br />
TAVR), by <strong>Valve</strong> Type (Mechanical & Tissue), Countries & Companies<br />
<strong>Global</strong> TMVR TAVR <strong>Market</strong><br />
Analyst View:<br />
<strong>Transcatheter</strong> heart valve market is anticipated to reach nearly US$ 7 Billion by 2024.<br />
Press Release Title:<br />
<strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong> will surpass US$ 6 Billion by year<br />
2024<br />
For more Info:<br />
https://www.renub.com/global-tmvr-tavr-market-nd.php<br />
Report Title:<br />
<strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong>, Patient Numbers, by Position<br />
(Transcather Mitral <strong>Valve</strong> <strong>Replacement</strong> and <strong>Transcatheter</strong> Aortic <strong>Valve</strong><br />
<strong>Replacement</strong>), <strong>Heart</strong> <strong>Valve</strong> Type (Mechanical & Tissue <strong>Heart</strong>) Countries (United<br />
States, Germany, China, France, Italy, Japan, Spain, United Kingdom, India and<br />
Brazil) Companies (Edward lifeScience Corporation, Boston Scientific Corporation, St<br />
Jude Medical Inc., Medtronics Inc)<br />
Access Full Research:<br />
https://www.renub.com/transcatheter-heart-valve-replacement-marketp.php<br />
© Renub Research Page 1 of 5 www.renub.com
<strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong>, Patient Numbers, by Position (TMVR,<br />
TAVR), by <strong>Valve</strong> Type (Mechanical & Tissue), Countries & Companies<br />
Get Free Customization in this Report<br />
The repair and replacement of heart valve with open heart surgery is a decade old technology.<br />
There are several heart valves that need to be either repair or replaced based on certain<br />
medical condition and recommendation by medical professional. The name of heart valves are<br />
based on their position like mitral valve, aortic valve and pulmonary valve. The repair of heart<br />
valve is quite easy procedure and mortality rate is quite low but replacement of heart valve is<br />
quite complicated procedure and mortality rate is very high. The replacement of mitral valve<br />
through open heart surgery is very complex procedure and involved high risk.<br />
Therefore <strong>Transcatheter</strong> Mitral <strong>Valve</strong> comes into picture as non-invasive technique that has less<br />
mortality rate. <strong>Transcatheter</strong> mitral valve replacement (TMVR) is gaining prominence after<br />
success of <strong>Transcatheter</strong> aortic valve replacement. Although Mitral <strong>Valve</strong> structure is very<br />
complex in nature but great success of TAVR opened the door of opportunities for<br />
<strong>Transcatheter</strong> Mitral <strong>Valve</strong> <strong>Replacement</strong> (TMVR). According to Renub Research,<br />
the transcatheter heart valve replacement market will surpass more than US$ 6 Billion by the<br />
end of year 2024.<br />
Request a free sample copy of the report: https://www.renub.com/contactus.php<br />
<strong>Market</strong> Landscape of <strong>Transcatheter</strong> Aortic <strong>Valve</strong> Implantation/<strong>Replacement</strong><br />
The TAVR market reached its growth phase due to rising aging population and increasing<br />
prevalence of aortic stenosis. The adoption of TAVR is increasing with rapid pace in developing<br />
countries and new devices getting approvals are the core factors that propel the market<br />
growth. The TAVR is quite expensive procedure than tradition procedure with lack of<br />
reimbursement policies is hampering the market growth. The transcatheter aortic valve<br />
replacement is a less invasive, catheter-based method for replacing non-functioning valve.<br />
There are three approach need to be followed while delivering aortic valve into heart.<br />
1. Transaortic Approach: Small incision on upper part of chest to access the aorta.<br />
2. Transapical Approach: Small incision will be made between chest and ribs to find lower<br />
part of the heart.<br />
3. Transfemoral Approach: Small incision to access the aorta via leg.<br />
<strong>Market</strong> Landscape of <strong>Transcatheter</strong> Mitral <strong>Valve</strong> <strong>Replacement</strong><br />
<strong>Transcatheter</strong> mitral valve is almost new technology and is in its infancy stage. According to<br />
industry expert, it will gain largest market share than TAVR by the end of year 2024. The<br />
Traditional mitral valve replacement involved lot of risk and complexities along with high<br />
mortality rate. Thus TMVR will create a space and likely to obsolete the traditional procedure<br />
via open heart surgery. The market of transcatheter mitral valve replacement will outperform<br />
in future course of time due to fast approvals of new devices by FDA and others agencies.<br />
© Renub Research Page 2 of 5 www.renub.com
<strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong>, Patient Numbers, by Position (TMVR,<br />
TAVR), by <strong>Valve</strong> Type (Mechanical & Tissue), Countries & Companies<br />
Client can Purchase this Report in Sections from below link:<br />
Access full Research: https://www.renub.com/transcatheter-heart-valvereplacement-market-p.php<br />
Moreover clinical trial of <strong>Transcatheter</strong> Mitral <strong>Valve</strong> replacement is growing at rapid pace<br />
across the world which will further fuel the market growth. There are two approach of<br />
delivering <strong>Transcatheter</strong> Mitral <strong>Valve</strong>:<br />
1. Transapical Approach: A small incision between chest and ribs to access the<br />
lowest part of heart.<br />
2. Transseptal Appoach: A small incision in the leg. The delivery system and valve<br />
will be guided from the right side of the heart to the mitral valve on the left side<br />
of the heart.<br />
Key Topics Covered<br />
1. Executive Summary<br />
2. <strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Market</strong> – <strong>Global</strong> Analysis<br />
2.1 <strong>Transcatheter</strong> Aortic <strong>Valve</strong> <strong>Market</strong><br />
2.2 <strong>Transcatheter</strong> Mitral <strong>Valve</strong> <strong>Market</strong><br />
© Renub Research Page 3 of 5 www.renub.com
<strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong>, Patient Numbers, by Position (TMVR,<br />
TAVR), by <strong>Valve</strong> Type (Mechanical & Tissue), Countries & Companies<br />
3. <strong>Global</strong> <strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> Patient Numbers<br />
4. <strong>Market</strong> Share – <strong>Global</strong> <strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> Analysis by Position (TAVR and TMVR)<br />
5. By Region – <strong>Market</strong> Analysis<br />
5.1 United States TAVR <strong>Market</strong><br />
5.2 Germany TAVR <strong>Market</strong><br />
5.3 China TAVR <strong>Market</strong><br />
5.4 France TAVR <strong>Market</strong><br />
5.5 Italy TAVR <strong>Market</strong><br />
5.6 Japan TAVR <strong>Market</strong><br />
5.7 Spain TAVR <strong>Market</strong><br />
5.8 United Kingdom TAVR <strong>Market</strong><br />
5.9 India TAVR <strong>Market</strong><br />
5.10 Brazil TAVR <strong>Market</strong><br />
6. By Region – <strong>Transcatheter</strong> Aortic <strong>Valve</strong> <strong>Replacement</strong> (TAVR) Patient Numbers<br />
6.1 United States TAVR Patient Numbers<br />
6.2 Germany TAVR Patient Numbers<br />
6.3 China TAVR Patient Number<br />
6.4 France TAVR Patient<br />
6.5 Italy TAVR Patient Numbers<br />
6.6 Japan TAVR Patient Numbers<br />
6.7 Spain TAVR Patient Number<br />
6.8 United Kingdom TAVR Patient Numbers<br />
6.9 India TAVR Patient Numbers<br />
6.10 Brazil TAVR Patient Numbers<br />
7. Region – <strong>Transcatheter</strong> Mitral <strong>Valve</strong> <strong>Replacement</strong> (TMVR) <strong>Market</strong><br />
7.1 Europe TMVR <strong>Market</strong><br />
7.2 United States TMVR <strong>Market</strong><br />
8. Region – <strong>Transcatheter</strong> Mitral <strong>Valve</strong> <strong>Replacement</strong> (TMVR) Patient Numbers<br />
8.1 Europe TMVR Patient<br />
8.2 United States TMVR Patient<br />
9. End-User – <strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong> & Patient Numbers<br />
9.1 Hospital <strong>Market</strong><br />
9.2 Hospital Patient Numbers<br />
9.3 Ambulatory Surgery Center <strong>Market</strong><br />
9.4 Ambulatory Surgery Center Patient Numbers<br />
10. Edwards Lifesciences Corporation – Company Analysis<br />
10.1 Merger / Acquisitions<br />
10.2 Company Sales Analysis<br />
11. Boston Scientific Corporation – Company Analysis<br />
11.1 Merger / Acquisition<br />
11.2 Company Sales Analysis<br />
12. St Jude medical Inc – Company Overview<br />
12.1 Company Sales Analysis<br />
© Renub Research Page 4 of 5 www.renub.com
<strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong> <strong>Replacement</strong> <strong>Market</strong>, Patient Numbers, by Position (TMVR,<br />
TAVR), by <strong>Valve</strong> Type (Mechanical & Tissue), Countries & Companies<br />
13. Medtronics – Company Analysis<br />
13.1 Merger / Acquisition<br />
13.2 Company Sales Analysis<br />
14. Growth Drivers<br />
14.1 Rising geriatric population, increase prevalence of heart valve disease in Elderly<br />
population<br />
14.2 Growing prevalence of mitral regurgitation and severe aortic stenosis disorder<br />
15. Challenges<br />
15.1 High Costs of <strong>Transcatheter</strong> <strong>Heart</strong> <strong>Valve</strong>s<br />
Medical Devices <strong>Market</strong> Reports:<br />
https://www.renub.com/medical-devices-15-c.php<br />
Renub Research - North America<br />
Rajat Gupta<br />
225 Kristie Ln, Roswell<br />
Georgia 30076, United States<br />
Renub Research - Asia<br />
Ankit Mishra<br />
C – 86, Sector – 10<br />
Noida 201301, India<br />
Tel: +1-678-302-0700<br />
Email: info@renub.com<br />
https://www.renub.com/<br />
Tel: +91-120-421-9822<br />
Email: info@renub.com<br />
https://www.renub.com/<br />
© Renub Research Page 5 of 5 www.renub.com
Change language